Cancer and the nuclear pore complex

Advances in Experimental Medicine and Biology

Volumn 773, Issue , 2014, Pages 285-307

  Simon, Dan N ^a   Rout, Michael P ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cancer; Leukemia; Nuclear envelope; Nuclear pore complex; Nucleoporin; Nup214; Nup358 RanBP2; Nup62; Nup88; Nup98; Tpr; Virus

Indexed keywords

CELL PROTEIN; NUCLEOPORIN; NUCLEOPORIN 214; NUCLEOPORIN 358; NUCLEOPORIN 62; NUCLEOPORIN 88; NUCLEOPORIN 98; TRANSLOCATED PROMOTER REGION; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CELL NUCLEUS MEMBRANE; CYTOPLASM; DNA DAMAGE; HUMAN; MURINE ENCEPHALOMYELITIS VIRUS; NEOPLASM; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; TRANSCRIPTION REGULATION; VESICULAR STOMATITIS VIRUS;

HUMANS; NEOPLASMS; NUCLEAR PORE;

EID: 84934436651     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-8032-8_13     Document Type: Article

References (164)

1. Alber F, Dokudovskaya S, Veenhoff LM, Zhang W, Kipper J, Devos D, Suprapto A, Karni-Schmidt O, Williams R, Chait BT, Sali A, Rout MP (2007) The molecular architecture of the nuclear pore complex. Nature 450(7170):695-701. doi: 10.1038/nature06405
2. Bilokapic S, Schwartz TU (2012) 3D ultrastructure of the nuclear pore complex. Curr Opin Cell Biol 24(1):86-91. doi: 10.1016/j.ceb.2011.12.011
3. Strambio-De-Castillia C, Niepel M, Rout MP (2010) The nuclear pore complex: bridging nuclear transport and gene regulation. Nat Rev Mol Cell Biol 11(7):490-501. doi: 10.1038/nrm2928
4. Raices M, D'Angelo MA (2012) Nuclear pore complex composition: a new regulator of tissue-specifi c and developmental functions. Nat Rev Mol Cell Biol 13(11):687-699. doi: 10.1038/nrm3461
5. Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ (2002) Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 158(5):915-927. doi: 10.1083/jcb.200206106
6. D'Angelo MA, Hetzer MW (2008) Structure, dynamics and function of nuclear pore complexes. Trends Cell Biol 18(10):456-466. doi: 10.1016/j.tcb.2008.07.009
7. Quimby BB, Lamitina T, L'Hernault SW, Corbett AH (2000) The mechanism of ran import into the nucleus by nuclear transport factor 2. J Biol Chem 275(37):28575-28582. doi: 10.1074/jbc.M005055200
8. Stewart M (2007) Ratcheting mRNA out of the nucleus. Mol Cell 25(3):327-330. doi: 10.1016/j.molcel.2007.01.016
9. Joseph J, Dasso M (2008) The nucleoporin Nup358 associates with and regulates interphase microtubules. FEBS Lett 582(2):190-196. doi: 10.1016/j.febslet.2007.11.087
10. Cai Y, Singh BB, Aslanukov A, Zhao H, Ferreira PA (2001) The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain. J Biol Chem 276(45):41594-41602. doi: 10.1074/jbc. M104514200
11. Singh BB, Patel HH, Roepman R, Schick D, Ferreira PA (1999) The zinc fi nger cluster domain of RanBP2 is a specifi c docking site for the nuclear export factor, exportin-1. J Biol Chem 274(52):37370-37378
12. Akhtar A, Gasser SM (2007) The nuclear envelope and transcriptional control. Nat Rev Genet 8(7):507-517. doi: 10.1038/nrg2122
13. Nakano H, Funasaka T, Hashizume C, Wong RW (2010) Nucleoporin translocated promoter region (Tpr) associates with dynein complex, preventing chromosome lagging formation during mitosis. J Biol Chem 285(14):10841-10849. doi: 10.1074/jbc.M110.105890
14. Towbin BD, Meister P, Gasser SM (2009) The nuclear envelope- A scaffold for silencing? Curr Opin Genet Dev 19(2):180-186. doi: 10.1016/j.gde.2009.01.006
15. Kalverda B, Pickersgill H, Shloma VV, Fornerod M (2010) Nucleoporins directly stimulate expression of developmental and cell-cycle genes inside the nucleoplasm. Cell 140(3): 360-371. doi: 10.1016/j.cell.2010.01.011
16. Capelson M, Hetzer MW (2009) The role of nuclear pores in gene regulation, development and disease. EMBO Rep 10(7):697-705. doi: 10.1038/embor.2009.147
17. Xu S, Powers MA (2009) Nuclear pore proteins and cancer. Semin Cell Dev Biol 20(5): 620-630. doi: 10.1016/j.semcdb.2009.03.003
18. Gough SM, Slape CI, Aplan PD (2011) NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 118(24):6247-6257. doi: 10.1182/blood-2011-07-328880
19. Franks TM, Hetzer MW (2013) The role of Nup98 in transcription regulation in healthy and diseased cells. Trends Cell Biol 23(3):112-117. doi: 10.1016/j.tcb.2012.10.013
20. Kohler A, Hurt E (2010) Gene regulation by nucleoporins and links to cancer. Mol Cell 38(1):6-15. doi: 10.1016/j.molcel.2010.01.040
21. Chow KH, Factor RE, Ullman KS (2012) The nuclear envelope environment and its cancer connections. Nat Rev Cancer 12(3):196-209. doi: 10.1038/nrc3219
22. Simon DN, Wilson KL (2011) The nucleoskeleton as a genome-associated dynamic 'network of networks'. Nat Rev Mol Cell Biol 12(11):695-708. doi: 10.1038/nrm3207
23. Krull S, Dorries J, Boysen B, Reidenbach S, Magnius L, Norder H, Thyberg J, Cordes VC (2010) Protein Tpr is required for establishing nuclear pore-associated zones of heterochromatin exclusion. EMBO J 29(10):1659-1673. doi: 10.1038/emboj.2010.54
24. Ben-Efraim I, Frosst PD, Gerace L (2009) Karyopherin binding interactions and nuclear import mechanism of nuclear pore complex protein Tpr. BMC Cell Biol 10:74. doi: 10.1186/1471-2121-10-74
25. Frosst P, Guan T, Subauste C, Hahn K, Gerace L (2002) Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export. J Cell Biol 156(4):617-630. doi: 10.1083/jcb.200106046
26. Dieppois G, Iglesias N, Stutz F (2006) Cotranscriptional recruitment to the mRNA export receptor Mex67p contributes to nuclear pore anchoring of activated genes. Mol Cell Biol 26(21):7858-7870. doi: 10.1128/MCB.00870-06
27. Galy V, Gadal O, Fromont-Racine M, Romano A, Jacquier A, Nehrbass U (2004) Nuclear retention of unspliced mRNAs in yeast is mediated by perinuclear Mlp1. Cell 116(1): 63-73
28. Galy V, Olivo-Marin JC, Scherthan H, Doye V, Rascalou N, Nehrbass U (2000) Nuclear pore complexes in the organization of silent telomeric chromatin. Nature 403(6765):108-112. doi: 10.1038/47528
29. Lee SH, Sterling H, Burlingame A, McCormick F (2008) Tpr directly binds to Mad1 and Mad2 and is important for the Mad1-Mad2-mediated mitotic spindle checkpoint. Genes Dev 22(21):2926-2931. doi: 10.1101/gad.1677208
30. Luthra R, Kerr SC, Harreman MT, Apponi LH, Fasken MB, Ramineni S, Chaurasia S, Valentini SR, Corbett AH (2007) Actively transcribed GAL genes can be physically linked to the nuclear pore by the SAGA chromatin modifying complex. J Biol Chem 282(5): 3042-3049. doi: 10.1074/jbc.M608741200
31. Byrd DA, Sweet DJ, Pante N, Konstantinov KN, Guan T, Saphire AC, Mitchell PJ, Cooper CS, Aebi U, Gerace L (1994) Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinases, is localized to the cytoplasmic surface of the nuclear pore complex. J Cell Biol 127(6 Pt 1):1515-1526
32. Bangs P, Burke B, Powers C, Craig R, Purohit A, Doxsey S (1998) Functional analysis of Tpr: identifi cation of nuclear pore complex association and nuclear localization domains and a role in mRNA export. J Cell Biol 143(7):1801-1812
33. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, Vande Woude GF (1984) Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311(5981):29-33
34. Hays JL, Watowich SJ (2003) Oligomerization-induced modulation of TPR-MET tyrosine kinase activity. J Biol Chem 278(30):27456-27463. doi: 10.1074/jbc.M210648200
35. Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG, Vande Woude GF (1986) Mechanism of met oncogene activation. Cell 45(6):895-904
36. Peschard P, Park M (2007) From Tpr-Met to Met, tumorigenesis and tubes. Oncogene 26(9):1276-1285. doi: 10.1038/sj.onc.1210201
37. Rodrigues GA, Park M (1993) Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol Cell Biol 13(11):6711-6722
38. Soman NR, Correa P, Ruiz BA, Wogan GN (1991) The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci USA 88(11):4892-4896
39. Yu J, Miehlke S, Ebert MP, Hoffmann J, Breidert M, Alpen B, Starzynska T, Stolte Prof M, Malfertheiner P, Bayerdorffer E (2000) Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in fi rst-degree relatives. Cancer 88(8):1801-1806
40. Greco A, Miranda C, Pagliardini S, Fusetti L, Bongarzone I, Pierotti MA (1997) Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specifi c TRK oncogenes. Genes Chromosomes Cancer 19(2):112-123
41. Greco A, Miranda C, Pierotti MA (2010) Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Mol Cell Endocrinol 321(1):44-49. doi: 10.1016/j.mce.2009.10.009
42. Pierotti MA, Greco A (2006) Oncogenic rearrangements of the NTRK1/NGF receptor. Cancer Lett 232(1):90-98. doi: 10.1016/j.canlet.2005.07.043
43. Li F, Zhai YP, Tang YM, Wang LP, Wan PJ (2012) Identifi cation of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 51(9):890-897. doi: 10.1002/gcc.21973
44. Alfonso P, Canamero M, Fernandez-Carbonie F, Nunez A, Casal JI (2008) Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling. J Proteome Res 7(10):4247-4255. doi: 10.1021/pr800152u
45. van Deursen J, Boer J, Kasper L, Grosveld G (1996) G2 arrest and impaired nucleocytoplasmic transport in mouse embryos lacking the proto-oncogene CAN/Nup214. EMBO J 15(20):5574-5583
46. Bernad R, Engelsma D, Sanderson H, Pickersgill H, Fornerod M (2006) Nup214-Nup88 nucleoporin subcomplex is required for CRM1-mediated 60S preribosomal nuclear export. J Biol Chem 281(28):19378-19386. doi: 10.1074/jbc.M512585200
47. Hutten S, Kehlenbach RH (2006) Nup214 is required for CRM1-dependent nuclear protein export in vivo. Mol Cell Biol 26(18):6772-6785. doi: 10.1128/MCB.00342-06
48. Fornerod M, van Deursen J, van Baal S, Reynolds A, Davis D, Murti KG, Fransen J, Grosveld G (1997) The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88. EMBO J 16(4):807-816. doi: 10.1093/emboj/16.4.807
49. von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A, Grosveld G (1992) The translocation (6;9), associated with a specifi c subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specifi c dek-can mRNA. Mol Cell Biol 12(4):1687-1697
50. von Lindern M, van Baal S, Wiegant J, Raap A, Hagemeijer A, Grosveld G (1992) Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: characterization of the set gene. Mol Cell Biol 12(8):3346-3355
51. Privette Vinnedge LM, Kappes F, Nassar N, Wells SI (2013) Stacking the DEK: from chromatin topology to cancer stem cells. Cell Cycle 12(1):51-66. doi: 10.4161/cc.23121
52. Fornerod M, Boer J, van Baal S, Jaegle M, von Lindern M, Murti KG, Davis D, Bonten J, Buijs A, Grosveld G (1995) Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specifi c chromosome rearrangements. Oncogene 10(9):1739-1748
53. Van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Beverloo HB, van der Spek PJ, Stubbs A, Cools J, Nagata K, Fornerod M, Buijs-Gladdines J, Horstmann M, van Wering ER, Soulier J, Pieters R, Meijerink JP (2008) The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood 111(9):4668-4680. doi: 10.1182/blood-2007-09- 111872
54. Ageberg M, Drott K, Olofsson T, Gullberg U, Lindmark A (2008) Identifi cation of a novel and myeloid specifi c role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis. Genes Chromosomes Cancer 47(4):276-287. doi: 10.1002/gcc.20531
55. Saito S, Miyaji-Yamaguchi M, Nagata K (2004) Aberrant intracellular localization of SETCAN fusion protein, associated with a leukemia, disorganizes nuclear export. Int J Cancer 111(4):501-507. doi: 10.1002/ijc.20296
56. Fornerod M, Boer J, van Baal S, Morreau H, Grosveld G (1996) Interaction of cellular proteins with the leukemia specifi c fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN. Oncogene 13(8):1801-1808
57. Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, Vermeesch JR, Stul M, Dutta B, Boeckx N, Bosly A, Heimann P, Uyttebroeck A, Mentens N, Somers R, MacLeod RA, Drexler HG, Look AT, Gilliland DG, Michaux L, Vandenberghe P, Wlodarska I, Marynen P, Hagemeijer A (2004) Fusion of NUP214 to ABL1 on amplifi ed episomes in T-cell acute lymphoblastic leukemia. Nat Genet 36(10):1084-1089. doi: 10.1038/ng1425
58. De Braekeleer E, Douet-Guilbert N, Rowe D, Bown N, Morel F, Berthou C, Ferec C, De Braekeleer M (2011) ABL1 fusion genes in hematological malignancies: a review. Eur J Haematol 86(5):361-371. doi: 10.1111/j.1600-0609.2011.01586.x
59. De Keersmaecker K, Rocnik JL, Bernad R, Lee BH, Leeman D, Gielen O, Verachtert H, Folens C, Munck S, Marynen P, Fornerod M, Gilliland DG, Cools J (2008) Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore. Mol Cell 31(1):134-142. doi: 10.1016/j.molcel.2008. 05.005
60. Gorello P, La Starza R, Di Giacomo D, Messina M, Puzzolo MC, Crescenzi B, Santoro A, Chiaretti S, Mecucci C (2010) SQSTM1-NUP214: a new gene fusion in adult T-cell acute lymphoblastic leukemia. Haematologica 95(12):2161-2163. doi: 10.3324/haematol.2010.029769
61. Duran A, Linares JF, Galvez AS, Wikenheiser K, Flores JM, Diaz-Meco MT, Moscat J (2008) The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 13(4):343-354. doi: 10.1016/j.ccr.2008.02.001
62. Hiruma Y, Honjo T, Jelinek DF, Windle JJ, Shin J, Roodman GD, Kurihara N (2009) Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation. Blood 113(20):4894-4902. doi: 10.1182/blood-2008-08-173948
63. Martin P, Diaz-Meco MT, Moscat J (2006) The signaling adapter p62 is an important mediator of T helper 2 cell function and allergic airway infl ammation. EMBO J 25(15):3524-3533. doi: 10.1038/sj.emboj.7601250
64. Pursiheimo JP, Rantanen K, Heikkinen PT, Johansen T, Jaakkola PM (2009) Hypoxiaactivated autophagy accelerates degradation of SQSTM1/p62. Oncogene 28(3):334-344. doi: 10.1038/onc.2008.392
65. Rodriguez A, Duran A, Selloum M, Champy MF, Diez-Guerra FJ, Flores JM, Serrano M, Auwerx J, Diaz-Meco MT, Moscat J (2006) Mature-onset obesity and insulin resistance in mice defi cient in the signaling adapter p62. Cell Metab 3(3):211-222. doi: 10.1016/j.cmet.2006.01.011
66. Wooten MW, Geetha T, Seibenhener ML, Babu JR, Diaz-Meco MT, Moscat J (2005) The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by infl uencing TRAF6 polyubiquitination. J Biol Chem 280(42):35625-35629. doi: 10.1074/jbc.C500237200
67. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW (2004) Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 24(18):8055-8068. doi: 10.1128/MCB.24.18.8055-8068.2004
68. Nowak NJ, Sait SN, Zeidan A, Deeb G, Gaile D, Liu S, Ford L, Wallace PK, Wang ES, Wetzler M (2010) Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet 199(1):15-20. doi: 10.1016/j. cancergencyto.2010.01.014
69. Bernad R, van der Velde H, Fornerod M, Pickersgill H (2004) Nup358/RanBP2 attaches to the nuclear pore complex via association with Nup88 and Nup214/CAN and plays a supporting role in CRM1-mediated nuclear protein export. Mol Cell Biol 24(6):2373-2384
70. Forler D, Rabut G, Ciccarelli FD, Herold A, Kocher T, Niggeweg R, Bork P, Ellenberg J, Izaurralde E (2004) RanBP2/Nup358 provides a major binding site for NXF1-p15 dimers at the nuclear pore complex and functions in nuclear mRNA export. Mol Cell Biol 24(3):1155-1167
71. Hutten S, Walde S, Spillner C, Hauber J, Kehlenbach RH (2009) The nuclear pore component Nup358 promotes transportin-dependent nuclear import. J Cell Sci 122(Pt 8):1100-1110. doi: 10.1242/jcs.040154
72. Matunis MJ, Wu J, Blobel G (1998) SUMO-1 modifi cation and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J Cell Biol 140(3):499-509
73. Pichler A, Gast A, Seeler JS, Dejean A, Melchior F (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108(1):109-120
74. Reverter D, Lima CD (2005) Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature 435(7042):687-692. doi: 10.1038/nature03588
75. Wu J, Matunis MJ, Kraemer D, Blobel G, Coutavas E (1995) Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fi ngers, a cyclophilin A homologous domain, and a leucine-rich region. J Biol Chem 270(23):14209-14213
76. Hamada M, Haeger A, Jeganathan KB, van Ree JH, Malureanu L, Walde S, Joseph J, Kehlenbach RH, van Deursen JM (2011) Ran-dependent docking of importin-beta to RanBP2/Nup358 fi laments is essential for protein import and cell viability. J Cell Biol 194(4):597-612. doi: 10.1083/jcb.201102018
77. Salina D, Enarson P, Rattner JB, Burke B (2003) Nup358 integrates nuclear envelope breakdown with kinetochore assembly. J Cell Biol 162(6):991-1001. doi: 10.1083/jcb.200304080
78. Gervais C, Dano L, Perrusson N, Helias C, Jeandidier E, Galoisy AC, Ittel A, Herbrecht R, Bilger K, Mauvieux L (2013) A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/ myelodysplastic neoplasm. Leukemia 27(5):1186-1188. doi: 10.1038/leu.2012.286
79. Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge JA (2003) Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in infl ammatory myofi broblastic tumor. Genes Chromosomes Cancer 37(1):98-105. doi: 10.1002/gcc.10177
80. Chen ST, Lee JC (2008) An infl ammatory myofi broblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features. Hum Pathol 39(12):1854-1858. doi: 10.1016/j.humpath.2008.04.016
81. Patel AS, Murphy KM, Hawkins AL, Cohen JS, Long PP, Perlman EJ, Griffi n CA (2007) RANBP2 and CLTC are involved in ALK rearrangements in infl ammatory myofi broblastic tumors. Cancer Genet Cytogenet 176(2):107-114. doi: 10.1016/j.cancergencyto.2007.04.004
82. Gylfe AE, Kondelin J, Turunen M, Ristolainen H, Katainen R, Pitkanen E, Kaasinen E, Rantanen V, Tanskanen T, Varjosalo M, Lehtonen H, Palin K, Taipale M, Taipale J, Renkonen-Sinisalo L, Jarvinen H, Bohm J, Mecklin JP, Ristimaki A, Kilpivaara O, Tuupanen S, Karhu A, Vahteristo P, Aaltonen LA (2013) Identifi cation of candidate oncogenes in human colorectal cancers with microsatellite instability. Gastroenterology. doi: 10.1053/j.gastro.2013.05.015
83. Dawlaty MM, Malureanu L, Jeganathan KB, Kao E, Sustmann C, Tahk S, Shuai K, Grosschedl R, van Deursen JM (2008) Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell 133(1):103-115. doi: 10.1016/j.cell.2008.01.045
84. Culjkovic-Kraljacic B, Baguet A, Volpon L, Amri A, Borden KL (2012) The oncogene eIF4E reprograms the nuclear pore complex to promote mRNA export and oncogenic transformation. Cell Rep 2(2):207-215. doi: 10.1016/j.celrep.2012.07. 007
85. Griffi s ER, Xu S, Powers MA (2003) Nup98 localizes to both nuclear and cytoplasmic sides of the nuclear pore and binds to two distinct nucleoporin subcomplexes. Mol Biol Cell 14(2):600-610. doi: 10.1091/mbc.E02-09-0582
86. Radu A, Moore MS, Blobel G (1995) The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex. Cell 81(2):215-222
87. Griffi s ER, Altan N, Lippincott-Schwartz J, Powers MA (2002) Nup98 is a mobile nucleoporin with transcription-dependent dynamics. Mol Biol Cell 13(4):1282-1297. doi: 10.1091/mbc.01-11-0538
88. Griffi s ER, Craige B, Dimaano C, Ullman KS, Powers MA (2004) Distinct functional domains within nucleoporins Nup153 and Nup98 mediate transcription-dependent mobility. Mol Biol Cell 15(4):1991-2002. doi: 10.1091/mbc.E03-10-0743
89. Capelson M, Liang Y, Schulte R, Mair W, Wagner U, Hetzer MW (2010) Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes. Cell 140(3): 372-383. doi: 10.1016/j.cell.2009.12.054
90. Liang Y, Franks TM, Marchetto MC, Gage FH, Hetzer MW (2013) Dynamic association of NUP98 with the human genome. PLoS Genet 9(2):e1003308. doi: 10.1371/journal.pgen.1003308
91. Iwamoto M, Asakawa H, Hiraoka Y, Haraguchi T (2010) Nucleoporin Nup98: a gatekeeper in the eukaryotic kingdoms. Genes Cells 15(7):661-669. doi: 10.1111/j.1365-2443.2010.01415.x
92. Borrow J, Shearman AM, Stanton VP Jr, Becher R, Collins T, Williams AJ, Dube I, Katz F, Kwong YL, Morris C, Ohyashiki K, Toyama K, Rowley J, Housman DE (1996) The t(7;11) (p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet 12(2):159-167. doi: 10.1038/ng0296-159
93. Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen IM, Feinberg AP, Jenkins NA, Copeland NG, Shaughnessy JD Jr (1996) Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11) (p15;p15) in human myeloid leukaemia. Nat Genet 12(2):154-158. doi: 10.1038/ng0296-154
94. Kasper LH, Brindle PK, Schnabel CA, Pritchard CE, Cleary ML, van Deursen JM (1999) CREB binding protein interacts with nucleoporin-specifi c FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol Cell Biol 19(1):764-776
95. Gorello P, Nofrini V, Brandimarte L, Pierini V, Crescenzi B, Nozza F, Daniele G, Storlazzi CT, Di Giacomo D, Matteucci C, La Starza R, Mecucci C (2013) Inv(11)(p15q22)/NUP98-DDX10 fusion and isoforms in a new case of de novo acute myeloid leukemia. Cancer Genet 206(3):92-96. doi: 10.1016/j.cancergen. 2013.02.001
96. Lisboa S, Cerveira N, Bizarro S, Correia C, Vieira J, Torres L, Mariz JM, Teixeira MR (2013) POU1F1 is a novel fusion partner of NUP98 in acute myeloid leukemia with t(3;11)(p11;p15). Mol Cancer 12:5. doi: 10.1186/1476-4598-12-5
97. Soler G, Kaltenbach S, Dobbelstein S, Broccardo C, Radford I, Mozziconacci MJ, Bernard OA, Penard-Lacronique V, Delabesse E, Romana SP (2013) Identifi cation of GSX2 and AF10 as NUP98 partner genes in myeloid malignancies. Blood Cancer J 3:e124. doi: 10.1038/bcj.2013.20
98. Shah N, Sukumar S (2010) The Hox genes and their roles in oncogenesis. Nat Rev Cancer 10(5):361-371. doi: 10.1038/nrc2826
99. Hussey DJ, Dobrovic A (2002) Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis. Blood 99(3):1097-1098
100. Wang GG, Cai L, Pasillas MP, Kamps MP (2007) NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 9(7):804-812. doi: 10.1038/ncb1608
101. Wang GG, Song J, Wang Z, Dormann HL, Casadio F, Li H, Luo JL, Patel DJ, Allis CD (2009) Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD fi nger. Nature 459(7248):847-851. doi: 10.1038/nature08036
102. Singer S, Zhao R, Barsotti AM, Ouwehand A, Fazollahi M, Coutavas E, Breuhahn K, Neumann O, Longerich T, Pusterla T, Powers MA, Giles KM, Leedman PJ, Hess J, Grunwald D, Bussemaker HJ, Singer RH, Schirmacher P, Prives C (2012) Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes. Mol Cell 48(5):799-810. doi: 10.1016/j.molcel.2012.09.020
103. Uv AE, Roth P, Xylourgidis N, Wickberg A, Cantera R, Samakovlis C (2000) members only encodes a Drosophila nucleoporin required for rel protein import and immune response activation. Genes Dev 14(15):1945-1957
104. Sabri N, Roth P, Xylourgidis N, Sadeghifar F, Adler J, Samakovlis C (2007) Distinct functions of the Drosophila Nup153 and Nup214 FG domains in nuclear protein transport. J Cell Biol 178(4):557-565. doi: 10.1083/jcb. 200612135
105. Xylourgidis N, Roth P, Sabri N, Tsarouhas V, Samakovlis C (2006) The nucleoporin Nup214 sequesters CRM1 at the nuclear rim and modulates NFkappaB activation in Drosophila. J Cell Sci 119(Pt 21):4409-4419. doi: 10.1242/jcs.03201
106. Martinez N, Alonso A, Moragues MD, Ponton J, Schneider J (1999) The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res 59(21):5408-5411
107. Gould VE, Martinez N, Orucevic A, Schneider J, Alonso A (2000) A novel, nuclear poreassociated, widely distributed molecule overexpressed in oncogenesis and development. Am J Pathol 157(5):1605-1613. doi: 10.1016/S0002-9440(10) 64798-0
108. Gould VE, Orucevic A, Zentgraf H, Gattuso P, Martinez N, Alonso A (2002) Nup88 (karyoporin) in human malignant neoplasms and dysplasias: correlations of immunostaining of tissue sections, cytologic smears, and immunoblot analysis. Hum Pathol 33(5):536-544
109. Agudo D, Gomez-Esquer F, Martinez-Arribas F, Nunez-Villar MJ, Pollan M, Schneider J (2004) Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer 109(5):717-720. doi: 10.1002/ijc.20034
110. Hernandez P, Sole X, Valls J, Moreno V, Capella G, Urruticoechea A, Pujana MA (2007) Integrative analysis of a cancer somatic mutome. Mol Cancer 6:13. doi: 10.1186/1476-4598-6-13
111. Kinoshita Y, Kalir T, Rahaman J, Dottino P, Kohtz DS (2012) Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy. Am J Pathol 180(1):375-389. doi: 10.1016/j.ajpath.2011. 09.024
112. Brustmann H, Hager M (2009) Nucleoporin 88 expression in normal and neoplastic squamous epithelia of the uterine cervix. Ann Diagn Pathol 13(5):303-307. doi: 10.1016/j. anndiagpath.2009.05.005
113. Zhao ZR, Zhang LJ, Wang YY, Li F, Wang MW, Sun XF (2012) Increased serum level of Nup88 protein is associated with the development of colorectal cancer. Med Oncol 29(3):1789-1795. doi: 10.1007/s12032-011-0047-1
114. Emterling A, Skoglund J, Arbman G, Schneider J, Evertsson S, Carstensen J, Zhang H, Sun XF (2003) Clinicopathological signifi cance of Nup88 expression in patients with colorectal cancer. Oncology 64(4):361-369. doi: 70294
115. Knoess M, Kurz AK, Goreva O, Bektas N, Breuhahn K, Odenthal M, Schirmacher P, Dienes HP, Bock CT, Zentgraf H, zur Hausen A (2006) Nucleoporin 88 expression in hepatitis B and C virus-related liver diseases. World J Gastroenterol 12(36):5870-5874
116. Zhang ZY, Zhao ZR, Jiang L, Li JC, Gao YM, Cui DS, Wang CJ, Schneider J, Wang MW, Sun XF (2007) Nup88 expression in normal mucosa, adenoma, primary adenocarcinoma and lymph node metastasis in the colorectum. Tumour Biol 28(2):93-99. doi: 10.1159/000099154
117. Takahashi N, van Kilsdonk JW, Ostendorf B, Smeets R, Bruggeman SW, Alonso A, van de Loo F, Schneider M, van den Berg WB, Swart GW (2008) Tumor marker nucleoporin 88 kDa regulates nucleocytoplasmic transport of NF-kappaB. Biochem Biophys Res Commun 374(3):424-430. doi: 10.1016/j.bbrc.2008.06.128
118. Kau TR, Way JC, Silver PA (2004) Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 4(2):106-117. doi: 10.1038/nrc1274
119. Culjkovic-Kraljacic B, Borden KL (2013) Aiding and abetting cancer: mRNA export and the nuclear pore. Trends Cell Biol 23(7):328-335. doi: 10.1016/j.tcb.2013.03.004
120. Pritchard CE, Fornerod M, Kasper LH, van Deursen JM (1999) RAE1 is a shuttling mRNA export factor that binds to a GLEBS-like NUP98 motif at the nuclear pore complex through multiple domains. J Cell Biol 145(2):237-254
121. Sitterlin D (2004) Characterization of the Drosophila Rae1 protein as a G1 phase regulator of the cell cycle. Gene 326:107-116
122. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, Lapuk A, Neve RM, Qian Z, Ryder T, Chen F, Feiler H, Tokuyasu T, Kingsley C, Dairkee S, Meng Z, Chew K, Pinkel D, Jain A, Ljung BM, Esserman L, Albertson DG, Waldman FM, Gray JW (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10(6):529-541. doi: 10.1016/j.ccr.2006.10. 009
123. Dominguez-Sanchez MS, Saez C, Japon MA, Aguilera A, Luna R (2011) Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers. BMC Cancer 11:77. doi: 10.1186/1471-2407-11-77
124. Guo S, Hakimi MA, Baillat D, Chen X, Farber MJ, Klein-Szanto AJ, Cooch NS, Godwin AK, Shiekhattar R (2005) Linking transcriptional elongation and messenger RNA export to metastatic breast cancers. Cancer Res 65(8):3011-3016. doi: 10.1158/0008-5472.CAN-04-3624
125. Guo S, Liu M, Godwin AK (2012) Transcriptional regulation of hTREX84 in human cancer cells. PLoS One 7(8):e43610. doi: 10.1371/journal.pone.0043610
126. Yang J, Li Y, Khoury T, Alrawi S, Goodrich DW, Tan D (2008) Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer. Ann Clin Lab Sci 38(2):105-112
127. Saito Y, Kasamatsu A, Yamamoto A, Shimizu T, Yokoe H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K (2013) ALY as a potential contributor to metastasis in human oral squamous cell carcinoma. J Cancer Res Clin Oncol 139(4):585-594. doi: 10.1007/s00432-012-1361-5
128. Fujimura S, Xing Y, Takeya M, Yamashita Y, Ohshima K, Kuwahara K, Sakaguchi N (2005) Increased expression of germinal center-associated nuclear protein RNA-primase is associated with lymphomagenesis. Cancer Res 65(13):5925-5934. doi: 10.1158/0008-5472. CAN-04-3259
129. Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KL (2006) eIF4E is a central node of an RNA regulon that governs cellular proliferation. J Cell Biol 175(3): 415-426. doi: 10.1083/jcb.200607020
130. Borden KL, Culjkovic-Kraljacic B (2010) Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond? Leuk Lymphoma 51(10):1805-1815. doi: 10.3109/10428194.2010.496506
131. Huang WY, Yue L, Qiu WS, Wang LW, Zhou XH, Sun YJ (2009) Prognostic value of CRM1 in pancreas cancer. Clin Invest Med 32(6):E315
132. Shen A, Wang Y, Zhao Y, Zou L, Sun L, Cheng C (2009) Expression of CRM1 in human gliomas and its signifi cance in p27 expression and clinical prognosis. Neurosurgery 65(1): 153-159. doi: 10.1227/01.NEU.0000348550.47441.4B , discussion 159-160
133. Turner JG, Dawson J, Sullivan DM (2012) Nuclear export of proteins and drug resistance in cancer. Biochem Pharmacol 83(8):1021-1032. doi: 10.1016/j.bcp.2011.12.016
134. van der Watt PJ, Maske CP, Hendricks DT, Parker MI, Denny L, Govender D, Birrer MJ, Leaner VD (2009) The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int J Cancer 124(8):1829-1840. doi: 10.1002/ijc.24146
135. Cohen S, Etingov I, Pante N (2012) Effect of viral infection on the nuclear envelope and nuclear pore complex. Int Rev Cell Mol Biol 299:117-159. doi: 10.1016/B978-0-12-394310-1.00003-5
136. Kobiler O, Drayman N, Butin-Israeli V, Oppenheim A (2012) Virus strategies for passing the nuclear envelope barrier. Nucleus 3(6):526-539. doi: 10.4161/nucl.21979
137. Kuss SK, Mata MA, Zhang L, Fontoura BM (2013) Nuclear imprisonment: viral strategies to arrest host mRNA nuclear export. Viruses 5(7):1824-1849. doi: 10.3390/v5071824
138. Gustin KE, Sarnow P (2001) Effects of poliovirus infection on nucleo-cytoplasmic traffi cking and nuclear pore complex composition. EMBO J 20(1-2):240-249. doi: 10.1093/emboj/20.1.240
139. Gustin KE, Sarnow P (2002) Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J Virol 76(17):8787-8796
140. Park N, Katikaneni P, Skern T, Gustin KE (2008) Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J Virol 82(4):1647-1655. doi: 10.1128/JVI.01670-07
141. Ghildyal R, Jordan B, Li D, Dagher H, Bardin PG, Gern JE, Jans DA (2009) Rhinovirus 3C protease can localize in the nucleus and alter active and passive nucleocytoplasmic transport. J Virol 83(14):7349-7352. doi: 10.1128/JVI.01748-08
142. Bardina MV, Lidsky PV, Sheval EV, Fominykh KV, van Kuppeveld FJ, Polyakov VY, Agol VI (2009) Mengovirus-induced rearrangement of the nuclear pore complex: hijacking cellular phosphorylation machinery. J Virol 83(7):3150-3161. doi: 10.1128/JVI.01456-08
143. Porter FW, Palmenberg AC (2009) Leader-induced phosphorylation of nucleoporins correlates with nuclear traffi cking inhibition by cardioviruses. J Virol 83(4):1941-1951. doi: 10.1128/JVI.01752-08
144. Ricour C, Delhaye S, Hato SV, Olenyik TD, Michel B, van Kuppeveld FJ, Gustin KE, Michiels T (2009) Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein. J Gen Virol 90(Pt 1):177-186. doi: 10.1099/vir.0.005678-0
145. Lidsky PV, Hato S, Bardina MV, Aminev AG, Palmenberg AC, Sheval EV, Polyakov VY, van Kuppeveld FJ, Agol VI (2006) Nucleocytoplasmic traffi c disorder induced by cardioviruses. J Virol 80(6):2705-2717. doi: 10.1128/JVI.80.6.2705-2717.2006
146. Chang CW, Lee CP, Huang YH, Yang PW, Wang JT, Chen MR (2012) Epstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins. J Virol 86(15):8072-8085. doi: 10.1128/JVI.01058-12
147. Strunze S, Engelke MF, Wang IH, Puntener D, Boucke K, Schleich S, Way M, Schoenenberger P, Burckhardt CJ, Greber UF (2011) Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection. Cell Host Microbe 10(3):210-223. doi: 10.1016/j.chom.2011.08.010
148. Copeland AM, Newcomb WW, Brown JC (2009) Herpes simplex virus replication: roles of viral proteins and nucleoporins in capsid-nucleus attachment. J Virol 83(4):1660-1668. doi: 10.1128/JVI.01139-08
149. Pasdeloup D, Blondel D, Isidro AL, Rixon FJ (2009) Herpesvirus capsid association with the nuclear pore complex and viral DNA release involve the nucleoporin CAN/Nup214 and the capsid protein pUL25. J Virol 83(13):6610-6623. doi: 10.1128/JVI.02655-08
150. Chakraborty P, Seemann J, Mishra RK, Wei JH, Weil L, Nussenzveig DR, Heiber J, Barber GN, Dasso M, Fontoura BM (2009) Vesicular stomatitis virus inhibits mitotic progression and triggers cell death. EMBO Rep 10(10):1154-1160. doi: 10.1038/embor.2009.179
151. Rajani KR, Pettit Kneller EL, McKenzie MO, Horita DA, Chou JW, Lyles DS (2012) Complexes of vesicular stomatitis virus matrix protein with host Rae1 and Nup98 involved in inhibition of host transcription. PLoS Pathog 8(9):e1002929. doi: 10.1371/journal.ppat.1002929
152. Balachandran S, Barber GN (2004) Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell 5(1):51-65
153. Barber GN (2005) VSV-tumor selective replication and protein translation. Oncogene 24(52):7710-7719. doi: 10.1038/sj.onc.1209042
154. Satterly N, Tsai PL, van Deursen J, Nussenzveig DR, Wang Y, Faria PA, Levay A, Levy DE, Fontoura BM (2007) Infl uenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci USA 104(6):1853-1858. doi: 10.1073/pnas.0610977104
155. Friedrich BM, Dziuba N, Li G, Endsley MA, Murray JL, Ferguson MR (2011) Host factors mediating HIV-1 replication. Virus Res 161(2):101-114. doi: 10.1016/j.virusres.2011.08.001
156. Lever AM, Jeang KT (2011) Insights into cellular factors that regulate HIV-1 replication in human cells. Biochemistry 50(6):920-931. doi: 10.1021/bi101805f
157. Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, Roth SL, Hue S, Fletcher AJ, Lee K, KewalRamani VN, Noursadeghi M, Jenner RG, James LC, Bushman FD, Towers GJ (2011) HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication effi ciency. PLoS Pathog 7(12):e1002439. doi: 10.1371/journal. ppat.1002439
158. Di Nunzio F, Danckaert A, Fricke T, Perez P, Fernandez J, Perret E, Roux P, Shorte S, Charneau P, Diaz-Griffero F, Arhel NJ (2012) Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration. PLoS One 7(9):e46037. doi: 10.1371/journal.pone.0046037
159. Di Nunzio F, Fricke T, Miccio A, Valle-Casuso JC, Perez P, Souque P, Rizzi E, Severgnini M, Mavilio F, Charneau P, Diaz-Griffero F (2013) Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. Virology 440(1):8-18. doi: 10.1016/j. virol.2013.02.008
160. Woodward CL, Prakobwanakit S, Mosessian S, Chow SA (2009) Integrase interacts with nucleoporin NUP153 to mediate the nuclear import of human immunodefi ciency virus type. J Virol 83(13):6522-6533. doi: 10.1128/JVI.02061-08
161. Monette A, Ajamian L, Lopez-Lastra M, Mouland AJ (2009) Human immunodefi ciency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV-1 gene expression. J Biol Chem 284(45):31350-31362. doi: 10.1074/jbc.M109.048736
162. Chan EY, Qian WJ, Diamond DL, Liu T, Gritsenko MA, Monroe ME, Camp DG II, Smith RD, Katze MG (2007) Quantitative analysis of human immunodefi ciency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J Virol 81(14):7571-7583. doi: 10.1128/JVI.00288-07
163. Chan EY, Sutton JN, Jacobs JM, Bondarenko A, Smith RD, Katze MG (2009) Dynamic host energetics and cytoskeletal proteomes in human immunodefi ciency virus type 1-infected human primary CD4 cells: analysis by multiplexed label-free mass spectrometry. J Virol 83(18):9283-9295. doi: 10.1128/JVI.00814-09
164. Monette A, Pante N, Mouland AJ (2011) HIV-1 remodels the nuclear pore complex. J Cell Biol 193(4):619-631. doi: 10.1083/jcb.201008064